Medibio appoints Olympian Michael Phelps to its Board

Company News

by Jessica Amir

Medibio Limited (ASX:MEB) has appointed world champion athlete and mental health advocate, Michael Phelps to its Board.

The mental health company appointed the decorated Olympian to its Board of Directors, as he previously worked with world-class doctors and medical experts on Medibio’s technology.

He also used the company’s technology to analyse his own personal datasets.

Michael Phelps believes Medibio will make a profound impact in diagnosing mental health disorders, particularly in sport, while its technology will empower people to seek much needed help and support.

Medibio says Michael Phelps will be a great addition to the Board, while his public profile will raising awareness of the mental health challenges.

Shares in Medibio Limited (ASX:MEB) are trading 10 per cent higher to 33 cents.
 

Subscribe to our Daily Newsletter?

Would you like to receive our daily news to your inbox?